Article
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
2024-09-11
Abstract excerpt
<h4>ABSTRACT</h4> Somatic mutations inactivating TET2 are among the most common drivers of clonal hematopoiesis (CH). While TET2 inactivation is associated with monocyte-derived inflammation and improved chimeric antigen-receptor-T cell function, its impact on immunotherapy response is unknown. In our mouse model, hematopoietic Tet2 mutation enhanced immune checkpoint blockade (ICB) response. Enhanced ICB respo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3cf27de1-40c1-5318-8686-965f141f4468
- DOI
- 10.1101/2024.09.09.612140
